#startup of the day 11 - Loopworm
July 20, 2026 | Monday | Features | By Vrushti Kothari
Roadmap for scaling innovation and market reach
Inception - 2019
Location - Bengaluru, India
Industry domain - Insect Biotechnology & Biomanufacturing
Founder - Ankit Alok Bagaria and Abhi Gawri (IIT Roorkee alumni)
Total team strength - 60+ employees, including 20+ scientists
Total funds raised - USD 6.65 million (USD 3.4M Seed in 2022 + USD 3.25M Pre-Series A in 2025)
Investors - Omnivore, Waterbridge Ventures, Enrission India Capital, Titan Capital and marquee angel investors.\
Supported by: Social Alpha (Tata Trusts), H&M Foundation, Ministry of Agriculture & Farmers Welfare, Department of Biotechnology (Government of India).
Revenue generated since inception - ~INR 20 crore
Key Highlights -
Raised USD 3.25M Pre-Series A to expand its silkworm recombinant protein platform.
Expanded to 10+ countries across 4 continents.
Secured international certifications including ISO 22000, HACCP, EU TRACES and CAA.
Recombinant protein R&D and pilot-scale infrastructure to produce custom proteins.
Founder Speaks -
The company is focused on commercialising its silkworm platform for the manufacturing of recombinant proteins across healthcare, diagnostics, biopharmaceuticals, and specialty enzymes. At the same time, it aims to scale its silkworm-derived proteins for animal nutrition by expanding its global footprint and increasing sales volumes across international markets.
